Jaguar Health (NASDAQ:JAGX) Stock Passes Above Fifty Day Moving Average – What’s Next?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Jaguar Health from a “sell” rating to a “hold” rating in a research report on Friday, September 13th.

Jaguar Health Trading Down 7.6 %

The firm has a 50 day moving average price of $1.02 and a two-hundred day moving average price of $1.52. The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC bought a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent quarter. 12.04% of the stock is owned by hedge funds and other institutional investors.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.